Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (9) 9
humans (8) 8
aged (7) 7
male (7) 7
female (6) 6
middle aged (6) 6
urology & nephrology (5) 5
aged, 80 and over (4) 4
kidney diseases (4) 4
acute kidney injury (3) 3
acute renal failure (3) 3
biomarkers - blood (3) 3
chronic kidney-disease (3) 3
ckd (3) 3
critical illness (3) 3
diabetes (3) 3
dialysis patients (3) 3
end-stage renal disease (3) 3
glomerular filtration rate (3) 3
hemodialysis (3) 3
hemofiltration (3) 3
hypertension (3) 3
renal dialysis - adverse effects (3) 3
stage renal-disease (3) 3
transplantation (3) 3
vascular calcification (3) 3
abridged index medicus (2) 2
angiotensin (2) 2
article (2) 2
blood pressure (2) 2
bone turnover (2) 2
calcification (2) 2
cardiovascular disease (2) 2
clinical trials (2) 2
creatinine (2) 2
diabetes mellitus (2) 2
dialysis (2) 2
double-blind method (2) 2
genetic markers (2) 2
heart attacks (2) 2
heart diseases (2) 2
kidney transplantation (2) 2
kidneys (2) 2
laboratory medicine & medical technology [human health sciences] (2) 2
medicine, general & internal (2) 2
médecine de laboratoire & technologie médicale [sciences de la santé humaine] (2) 2
nephropathy (2) 2
parathyroid hormone (2) 2
parathyroid hormone - blood (2) 2
phosphatase (2) 2
predictive value of tests (2) 2
renal dialysis (2) 2
renin (2) 2
risk factors (2) 2
sclerostin (2) 2
vascular calcification - blood (2) 2
25-hydroxycholecalciferol (1) 1
acid phosphatase (1) 1
acute kidney injury - diagnosis (1) 1
acute kidney injury - therapy (1) 1
acute-renal-failure (1) 1
adult-population (1) 1
age factors (1) 1
albumin (1) 1
albuminuria (1) 1
aldosterone (1) 1
alkaline phosphatase (1) 1
alkaline-phosphatase (1) 1
anaemia (1) 1
analogs (1) 1
anemia (1) 1
anemia, hypochromic - blood (1) 1
anemia, hypochromic - diagnosis (1) 1
anemia, hypochromic - drug therapy (1) 1
anemia, iron-deficiency - blood (1) 1
anemia, iron-deficiency - diagnosis (1) 1
anemia, iron-deficiency - drug therapy (1) 1
antihypertensive agents - standards (1) 1
antihypertensive agents - therapeutic use (1) 1
antihypertensive treatment (1) 1
automation (1) 1
awareness (1) 1
beam computed-tomography (1) 1
belgium - epidemiology (1) 1
biomarkers (1) 1
biomarkers - analysis (1) 1
blood pressure - drug effects (1) 1
blood pressure control (1) 1
body mass index (1) 1
body weight (1) 1
bone density conservation agents - administration & dosage (1) 1
bone diseases (1) 1
bone morphogenetic proteins - analysis (1) 1
bone morphogenetic proteins - blood (1) 1
bone-mineral density (1) 1
calcium (1) 1
calcium - metabolism (1) 1
calcium-binding proteins - blood (1) 1
cardiovascular diseases - etiology (1) 1
cardiovascular diseases - mortality (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Variations of parathyroid hormone and bone biomarkers are concordant only after a long term follow-up in hemodialyzed patients
by Delanaye, Pierre and Warling, Xavier and Moonen, Martial and Smelten, Nicole and Jouret, François and Krzesinski, Jean-Marie and Maillard, Nicolas and Pottel, Hans and Cavalier, Etienne
Scientific Reports, ISSN 2045-2322, 12/2017, Volume 7, Issue 1, pp. 12623 - 8
End-stage renal disease is associated with mineral and bone disorders. Guidelines recommending therapies should be based on serial assessments of biomarkers,... 
RENAL DYSFUNCTION | DIALYSIS PATIENTS | PTH | ALKALINE-PHOSPHATASE | MULTIDISCIPLINARY SCIENCES | SECONDARY HYPERPARATHYROIDISM | I COLLAGEN | INTERMETHOD VARIABILITY | CHRONIC KIDNEY-DISEASE | CKD | RESORPTION MARKER | Alkaline phosphatase | End-stage renal disease | Osteocalcin | Procollagen | Bone diseases | Phosphatase | Parathyroid hormone | Collagen | Biomarkers | Acid phosphatase (tartrate-resistant) | Kidney diseases | Variation | Parathyroid | Kidney transplantation | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Clinical and Biological Determinants of Sclerostin Plasma Concentration in Hemodialysis Patients
by Delanaye, Pierre and Krzesinski, Jean-Marie and Warling, Xavier and Moonen, Martial and Smelten, Nicole and Médart, Laurent and Bruyère, Olivier and Reginster, Jean-Yves and Pottel, Hans and Cavalier, Etienne
Nephron Clinical Practice, ISSN 1660-2110, 12/2014, Volume 128, Issue 1-2, pp. 127 - 134
Background: Sclerostin is a potent inhibitor of bone formation, but the meaning of its serum levels remains undetermined. We evaluated the association between... 
Original Paper | Vascular calcification | Sclerostin | Bone turnover | BONE-MINERAL DENSITY | CIRCULATING SCLEROSTIN | KIDNEY-FUNCTION | UROLOGY & NEPHROLOGY | SERUM SCLEROSTIN | SOST | POSTMENOPAUSAL WOMEN | CKD | STAGE RENAL-DISEASE | FAT MASS | Humans | Middle Aged | Vascular Calcification - blood | Aged, 80 and over | Female | Male | Aged | Bone Morphogenetic Proteins - blood | Biomarkers - blood | Genetic Markers | Parathyroid Hormone - blood | Renal Dialysis | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Dephosphorylated-uncarboxylated Matrix Gla protein concentration is predictive of vitamin K status and is correlated with vascular calcification in a cohort of hemodialysis patients
by Delanaye, Pierre and Krzesinski, Jean-Marie and Warling, Xavier and Moonen, Martial and Smelten, Nicole and Médart, Laurent and Pottel, Hans and Cavalier, Etienne
BMC Nephrology, ISSN 1471-2369, 09/2014, Volume 15, Issue 1, pp. 145 - 145
Background: Matrix Gla protein (MGP) is known to act as a potent local inhibitor of vascular calcifications. However, in order to be active, MGP must be... 
Vascular calcification | Matrix Gla protein | Vitamin K | YOUNG-ADULTS | MORTALITY | BEAM COMPUTED-TOMOGRAPHY | SMOOTH-MUSCLE | CORONARY-ARTERY CALCIFICATION | DIALYSIS PATIENTS | WARFARIN | CALCIUM | UROLOGY & NEPHROLOGY | CHRONIC KIDNEY-DISEASE | STAGE RENAL-DISEASE | Phosphorylation - physiology | Predictive Value of Tests | Humans | Middle Aged | Vascular Calcification - blood | Extracellular Matrix Proteins - blood | Male | Biomarkers - blood | Vitamin K - antagonists & inhibitors | Vitamin K - blood | Renal Dialysis - adverse effects | Aged, 80 and over | Female | Aged | Vascular Calcification - diagnosis | Calcium-Binding Proteins - blood | Cohort Studies | Albumin | Comparative analysis | Hypertension | Phosphorylation | Automation | Heart attacks | Mortality | Cardiovascular disease | Smooth muscle | Phosphatase | Vitamins | Proteins | Studies | Body mass index | Calcification | Population | Diabetes | Kidney diseases | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial
by Heerspink, Hiddo J L and Parving, Hans-Henrik and Andress, Dennis L and Bakris, George and Correa-Rotter, Ricardo and Hou, Fan-Fan and Hou, Fanfan and Kitzman, Dalane W and Kohan, Donald and Makino, Shinya and Makino, Hirofumi and McMurray, John J V and Melnick, Joel Z and Miller, Michael G and Miller, Alan and Miller, Steven and Pergola, Pablo E and Pergola, Pablo and Perkovic, Vlado and Tobe, Sheldon and Yi, Joo Hark and Yi, Tingting and Wigderson, Melissa and de Zeeuw, Dick and Elbert, Alicia and Vallejos, Augusto and Alvarisqueta, Andres and Maffei, Laura and Juncos, Luis and de Arteaga, Javier and Greloni, Gustavo and Farias, Eduardo and Zucchini, Alfredo and Vogel, Daniel and Cusumano, Ana and Santos, Juan and Fraenkel, Margaret and Gallagher, Martin and Davis, Tim and Acharya, Shamasunder and Cooke, Duncan and Suranyi, Michael and Roger, Simon and Toussaint, Nigel and Pollock, Carol and Chan, Doris and Stranks, Stephen and MacIsaac, Richard and Endre, Zoltan and Schmidt, Alice and Schmidt, Rebecca and Prager, Rudolf and Mayer, Gert and Warling, Xavier and Jadoul, Michel and Hougardy, Jean and Vercammen, Chris and Van Vlem, Bruno and Gillard, Pieter and Costa e Forti, Adriana and Borges, Joao Lindolfo and Santos Canani, Luis and Eliaschewitz, Freddy and Leite, Silmara and Fraige Filho, Fadlo and Paschoalin, Raphael and Moura Neto, Jose Andrade and Deboni, Luciane and de Lourdes Noronha, Irene and Cercato, Cintia and Prompt, Carlos Alberto and Zanella, Maria and Rassi, Nelson and D'Avila, Domingos and Milagres, Rosangela and Felicio, Joao and Pecoits Filho, Roberto and Riella, Miguel Carlos and Salles, Joao and Keitel, Elizete and Draibe, Sergio and Amodeo, Celso and Youmbissi, Joseph and Roy, Louise and Cournoyer, Serge and Jolly, Shivinder and Pichette, Vincent and Nesrallah, Gihad and Bajaj, Harpreet Singh and Khandwala, Hasnain and Aronson, Ronnie and Goluch, Richard and Tam, Paul and Rabbat, Christian and Bailey, Gordon and Chow, Stephen and Castillo, Alvaro and Danin Vargas, Alfredo and Gonzalez, Fernando and Munoz, Rodrigo and ... and SONAR Comm Investigators and SONAR Committees and Investigators
The Lancet, ISSN 0140-6736, 05/2019, Volume 393, Issue 10184, pp. 1937 - 1947
Short-term treatment for people with type 2 diabetes using a low dose of the selective endothelin A receptor antagonist atrasentan reduces albuminuria without... 
MEDICINE, GENERAL & INTERNAL | INHIBITION | ENDOTHELIN | ALBUMINURIA | NEPHROPATHY | Short term | Enrichment | End-stage renal disease | Renal function | Endothelin | Heart attacks | Peptides | Clinical trials | Cardiovascular disease | Transplantation | Retention | Randomization | Renin | Motivation | Hemoglobin | Blood pressure | Safety | Diabetes mellitus (non-insulin dependent) | Heart diseases | Drug dosages | Heart failure | Urine | Creatinine | Enzymes | Kidneys | Epidermal growth factor receptors | Anemia | Diabetes mellitus | Health risks | Patients | Disease control | Glomerular filtration rate | Sodium | Angiotensin | Renal failure | Dialysis | Kidney diseases | Diabetes | Surface area | Potassium | Kidney transplantation | Long-term effects | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Cholecalciferol in haemodialysis patients: A randomized, double-blind, proof-of-concept and safety study
by Delanaye, Pierre and Weekers, Laurent and Warling, Xavier and Moonen, Martial and Smelten, Nicole and Médart, Laurent and Krzesinski, Jean-Marie and Cavalier, Etienne
Nephrology Dialysis Transplantation, ISSN 0931-0509, 07/2013, Volume 28, Issue 7, pp. 1779 - 1786
Background. The role of cholecalciferol supplementation in end-stage renal disease (ESRD) patients has been questioned. The objective of this randomized... 
Vitamin D | Calcification | Parathormone | D THERAPY | vitamin D | parathormone | VASCULAR CALCIFICATION | D SUPPLEMENTATION | 25-HYDROXYCHOLECALCIFEROL | VITAMIN-D DEFICIENCY | HIGH-DOSE CHOLECALCIFEROL | TRANSPLANTATION | DIALYSIS PATIENTS | UROLOGY & NEPHROLOGY | MINERAL METABOLISM | calcification | CHRONIC KIDNEY-DISEASE | STAGE RENAL-DISEASE | Glomerular Filtration Rate | Double-Blind Method | Calcium - metabolism | Humans | Vitamin D Deficiency - drug therapy | Male | Bone Density Conservation Agents - administration & dosage | Parathyroid Hormone - blood | Vascular Calcification - drug therapy | Vitamin D - blood | Cholecalciferol - administration & dosage | Phosphorus - metabolism | Kidney Failure, Chronic - complications | Renal Dialysis - adverse effects | Female | Vitamin D - analogs & derivatives | Aged | Vitamin D Deficiency - etiology | Dietary Supplements | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Variations of sclerostin with other bone biomarkers over a one-year period in hemodialysis patients
by Paquot, François and Delanaye, Pierre and Warling, Xavier and Moonen, Martial and Smelten, Nicole and Jouret, François and Krzesinski, Jean-Marie and Maillard, Nicolas and Pottel, Hans and Evenepoel, Pieter and Cavalier, Etienne
Clinica Chimica Acta, ISSN 0009-8981, 11/2018, Volume 486, pp. 183 - 184
Sclerostin | Dialysis | Bone turnover | Parathyroid hormone | DISEASE | DBone turnover | MEDICAL LABORATORY TECHNOLOGY | RENAL OSTEODYSTROPHY | Bone Morphogenetic Proteins - analysis | Chronic Kidney Disease-Mineral and Bone Disorder - therapy | Humans | Middle Aged | Biomarkers - analysis | Aged, 80 and over | Female | Male | Aged | Genetic Markers | Chronic Kidney Disease-Mineral and Bone Disorder - diagnosis | Renal Dialysis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Mature erythrocyte parameters as new markers of functional iron deficiency in haemodialysis: sensitivity and specificity
by Bovy, Christophe and Gothot, André and Delanaye, Pierre and Warling, Xavier and Krzesinski, Jean-Marie and Beguin, Yves
Nephrology Dialysis Transplantation, ISSN 0931-0509, 4/2007, Volume 22, Issue 4, pp. 1156 - 1162
Background. The percentage of hypochromic red blood cells (RBCs) (%HYPO) has been demonstrated as the best predictor of response to iron loading in... 
Percentage of hypochromic red blood cells | Haemodialysis | Anaemia | Iron monitoring | Mature erythrocyte parameters | iron monitoring | anaemia | QUALITY | RECOMBINANT-HUMAN-ERYTHROPOIETIN | INTRAVENOUS IRON | haemodialysis | RISK | TRANSPLANTATION | SUPPLEMENTATION | IMPACT | THERAPY | UROLOGY & NEPHROLOGY | mature erythrocyte parameters | percentage of hypochromic red blood cells | LIFE | Anemia, Hypochromic - diagnosis | Anemia, Hypochromic - drug therapy | Predictive Value of Tests | Anemia, Iron-Deficiency - drug therapy | Erythropoietin - therapeutic use | Humans | Middle Aged | Hemoglobins - metabolism | Male | Biomarkers - blood | Anemia, Iron-Deficiency - blood | Erythropoiesis - physiology | Kidney Failure, Chronic - therapy | Sensitivity and Specificity | Anemia, Iron-Deficiency - diagnosis | Renal Dialysis - adverse effects | Aged, 80 and over | Erythrocytes - pathology | Anemia, Hypochromic - blood | Female | Aged | Erythrocyte Count | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Myostatin and Insulin-Like Growth Factor 1 Are Biomarkers of Muscle Strength, Muscle Mass, and Mortality in Patients on Hemodialysis
by Delanaye, Pierre and Bataille, Stanislas and Quinonez, Kevin and Buckinx, Fanny and Warling, Xavier and Krzesinski, Jean-Marie and Pottel, Hans and Burtey, Stéphane and Bruyère, Olivier and EuSpLM, Etienne Cavalier
Journal of Renal Nutrition, ISSN 1051-2276, 2019
Muscle strength is frequently altered in hemodialysis patients. In the present work, five potential muscle biomarkers have been studied in their ability to... 
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Survey on treatment of hypertension and implementation of World Health Organization/International Society of Hypertension risk stratification in primary care in Belgium
by Fagard, Robert H and Van den Enden, Maria and Leeman, Marc and Warling, Xavier
Journal of Hypertension, ISSN 0263-6352, 07/2002, Volume 20, Issue 7, pp. 1297 - 1302
OBJECTIVE To gain insight into the prevalence, treatment and control of hypertension and into the implementation of the 1999 World Health... 
Hypertension | Antihypertensive treatment | Blood pressure control | Primary care | Risk stratification | Guidelines | antihypertensive treatment | risk stratification | MANAGEMENT | ADULT-POPULATION | GENERAL-PRACTICE | PREVALENCE | blood pressure control | AWARENESS | TRENDS | FRANCE | SYSTOLIC BLOOD-PRESSURE | OLDER PATIENTS | guidelines | primary care | PERIPHERAL VASCULAR DISEASE | hypertension | Guideline Adherence - statistics & numerical data | Prevalence | Prospective Studies | Age Factors | Humans | Middle Aged | Systole - drug effects | Hypertension - drug therapy | Male | Primary Health Care - standards | Societies, Medical | Family Practice - standards | Blood Pressure - drug effects | Diastole - drug effects | Hypertension - epidemiology | Antihypertensive Agents - standards | Severity of Illness Index | World Health Organization | Belgium - epidemiology | Cross-Sectional Studies | Risk Assessment | Hypertension - classification | Risk Factors | Treatment Outcome | Antihypertensive Agents - therapeutic use | Regression Analysis | Aged | Health Care Surveys | Practice Guidelines as Topic | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Acute kidney injury: From concept to practice
by Moonen, Martial and Fraipont, Vincent and Radermacher, Luc and Masset, Catherine and Firre, Éric and Warling, Xavier
Nephrologie et Therapeutique, ISSN 1769-7255, 2011, Volume 7, Issue 3, pp. 172 - 177
Definition and classification of acute renal failure evolved in recent years. The acronym "Acute Kidney Injury" replaces "Acute Renal Failure". The RIFLE... 
Critical illness | Hemodialysis | Acute kidney injury | Hemofiltration | Acute renal failure
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text L’insuffisance rénale aiguë : du concept à la pratique
by Moonen, Martial and Fraipont, Vincent and Radermacher, Luc and Masset, Catherine and Firre, Éric and Warling, Xavier
Néphrologie & Thérapeutique, ISSN 1769-7255, 2011, Volume 7, Issue 3, pp. 172 - 177
La définition et la classification de l’insuffisance rénale aiguë ont évolué ces dernières années. L’acronyme « Acute Kidney Injury » (AKI) remplace « Acute... 
Critical illness | Insuffisance rénale aiguë | Soins intensifs | Hemodialysis | Acute kidney injury | Hemofiltration | Hémofiltration | Hémodialyse | Acute renal failure | Maladie rénale
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Acute kidney injury: From concept to practice
by Moonen, M and Fraipont, V and Radermacher, L and Masset, C and Eric, F and Warling, X
NEPHROLOGIE & THERAPEUTIQUE, ISSN 1769-7255, 06/2011, Volume 7, Issue 3, pp. 172 - 177
Definition and classification of acute renal failure evolved in recent years. The acronym "Acute Kidney Injury" replaces "Acute Renal Failure". The RIFLE... 
Critical illness | Hemodialysis | CONTINUOUS VENOVENOUS HEMOFILTRATION | Acute kidney injury | RANDOMIZED-TRIAL | ACUTE-RENAL-FAILURE | N-ACETYLCYSTEINE | GELATINASE-ASSOCIATED LIPOCALIN | Acute renal failure | SERUM CYSTATIN-C | INTENSIVE-CARE-UNIT | Hemofiltration | REPLACEMENT THERAPY | UROLOGY & NEPHROLOGY | CONTRAST-INDUCED NEPHROPATHY | CRITICALLY-ILL PATIENTS | Humans | Acute Kidney Injury - therapy | Acute Kidney Injury - diagnosis | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease
by de Zeeuw, Dick and Akizawa, Tadao and Audhya, Paul and Bakris, George L and Chin, Melanie and Christ-Schmidt, Heidi and Goldsberry, Angie and Houser, Mark and Krauth, Melissa and Lambers Heerspink, Hiddo J and McMurray, John J and Meyer, Colin J and Parving, Hans-Henrik and Remuzzi, Giuseppe and Toto, Robert D and Vaziri, Nosratola D and Wanner, Christoph and Wittes, Janet and Wrolstad, Danielle and Chertow, Glenn M and BEACON Trial Investigators
The New England Journal of Medicine, ISSN 0028-4793, 12/2013, Volume 369, Issue 26, pp. 2492 - 2503
Among patients with type 2 diabetes and stage 4 chronic kidney disease, bardoxolone methyl, as compared with placebo, did not reduce the risk of end-stage... 
TRIAL | MEDICINE, GENERAL & INTERNAL | NRF2 | ANALOGS | RENAL EVENTS BEACON | OUTCOMES | IRBESARTAN | NEPHROPATHY | CKD | Cardiovascular Diseases - etiology | Glomerular Filtration Rate | Double-Blind Method | Humans | Middle Aged | Oleanolic Acid - analogs & derivatives | Kaplan-Meier Estimate | Diabetic Nephropathies - drug therapy | Male | Weight Loss - drug effects | Renal Insufficiency, Chronic - physiopathology | Renal Insufficiency, Chronic - drug therapy | Kidney Failure, Chronic - prevention & control | NF-E2-Related Factor 2 - metabolism | Treatment Failure | Intention to Treat Analysis | Cardiovascular Diseases - mortality | Female | Oleanolic Acid - adverse effects | Aged | Oleanolic Acid - therapeutic use | Diabetes Mellitus, Type 2 - complications | Kidney Failure, Chronic - etiology | Evaluation | Care and treatment | Dosage and administration | Terpenes | Risk factors | Diabetic nephropathies | Hypertension | Creatinine | End-stage renal disease | Oxidative stress | Kidneys | Diabetes mellitus | Body weight | Clinical trials | Aldosterone | Glomerular filtration rate | Renin | Angiotensin | Blood pressure | Diabetes | Kidney diseases | Diabetes mellitus (non-insulin dependent) | Heart diseases | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights